News Channels

30 Dec 2019 Savara Granted Breakthrough Therapy Designation for Molgradex for the Treatment of Autoimmune Pulmonary Alveolar Proteinosis (aPAP)
30 Dec 2019 Milestone for Biopharmaceuticals in China
30 Dec 2019 Acceleron and Fulcrum Therapeutics Announce Pulmonary Research and Discovery Collaboration Agreement
30 Dec 2019 Clover Biopharmaceuticals Initiates Phase III Study of Etanercept Biosimilar Candidate SCB-808 in China
30 Dec 2019 Commencement of phase 1 trial for AZD0466 utilising DEP
30 Dec 2019 Lynparza approved in the US as a 1st-line maintenance treatment of germline BRCA-mutated metastatic pancreatic cancer
28 Dec 2019 China National Medical Products Administration Approves BeiGene’s Tislelizumab for Patients with Classical Hodgkin’s Lymphoma Who Have Received at Least Two Prior Therapies
28 Dec 2019 First Patient Dosed in Phase 1 Clinical Study of Tafasitamab in Firstline DLBCL
27 Dec 2019 Sinovac Announces Approval of Varicella Vaccine for Prevention of Varicella-Zoster Virus (Chickenpox) in Children
27 Dec 2019 Astellas Strengthens Immuno-oncology Pipeline with Acquisition of Xyphos Biosciences, Inc.
26 Dec 2019 Spring Bank Stops Dosing of Inarigivir Patients in Phase 2 Program
26 Dec 2019 Prevail Therapeutics Announces IND Active for PR001 for Treatment of Neuronopathic Gaucher Disease
26 Dec 2019 Immunomedics Announces FDA Acceptance for Filing of Biologics License Application Resubmission for Sacituzumab Govitecan to Treat Metastatic Triple-Negative Breast Cancer
26 Dec 2019 Spectrum Pharmaceuticals Provides Pipeline Update on Late Stage Programs
24 Dec 2019 Allergan Receives U.S. FDA Approval for UBRELVY™ for the Acute Treatment of Migraine with or without Aura in Adults
24 Dec 2019 NewLink Genetics Announces Exclusive Worldwide License Agreement with Ellipses Pharma for Development of and Rights to Commercialization of NLG207
24 Dec 2019 Gilead and Eisai Enter Into Agreement in Japan for the Co-Promotion of the Investigational Rheumatoid Arthritis Therapy Filgotinib, Pending Regulatory Approval
23 Dec 2019 Sarepta Therapeutics Announces Partnership with Roche in Territories Outside the United States for its Investigational Micro-dystrophin Gene Therapy for Duchenne Muscular Dystrophy, SRP-9001
23 Dec 2019 Trevena Announces Initiation of Proof-of-Concept Study for TRV734 for Potential Treatment of Opioid Use Disorder
23 Dec 2019 FDA Approves Intra-Cellular Therapies’ Novel Antipsychotic, CAPLYTA® (lumateperone) for the Treatment of Schizophrenia in Adults

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2018 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up